Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | TACR2 | P21452 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11422922 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL981210 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL2972954 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL981404 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL983609 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL817463 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL985513 | 1.00 | TYR (0.39) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL814781 | 0.98 | TYR (0.36) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL814841 | 0.92 | SKP2 (0.35) | TYRHTT | |
| SCHEMBL983487 | 0.85 | ESR1 (0.36) | TYRESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| WO-2023080257-A1 | METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| WO-2023080258-A1 | CARBONYL COMPOUND, METHOD FOR PRODUCING CARBONYL COMPOUND, METHOD FOR PRODUCING ISOCYANATE COMPOUND, AND ISOCYANATE COMPOSITION | 旭化成株式会社 | 2023-05-11 | — | — | WO | disclosed |
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-9233918-B2 | Isocyanate production process | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9163046-B2 | Process for producing substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-10-20 | — | — | US | disclosed |
| EP-2088138-B1 | Process for producing isocyanate | ASAHI KASEI CHEMICALS CORP (JP) | 2013-02-27 | — | — | EP | disclosed |
| US-8362293-B2 | Process for producing isocyanates | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| US-5756565-A | STORAGE STABLE COMPOSITION, CROSSLINKED WITH SULFUR IN BITUMINOUS MATRIX | ELF ANTAR FRANCE (FR) | 1998-05-26 | — | — | US | disclosed |
| EP-0554679-A1 | Process for the preparation of alpha-Chloro 2,4,6-trimethylacetophenone | BASF Aktiengesellschaft (DE) | 1993-08-11 | — | — | EP | disclosed |
| EP-0211271-B1 | PROCESS FOR THE PREPARATION OF VERATRYL CYANIDE | BASF Aktiengesellschaft (DE) | 1988-10-12 | — | — | EP | disclosed |
| EP-0142797-B1 | METHOD FOR THE PREPARATION OF ACETONITRILES SUBSTITUTED IN POSITION 2 BY AN AROMATIC OR HETEROCYCLIC SUBSTITUENT | BASF Aktiengesellschaft (DE) | 1988-07-13 | — | — | EP | disclosed |
| US-4661610-A | Preparation of veratryl cyanide | BASF AKTIENGESELLSCHAFT (DE) | 1987-04-28 | — | — | US | disclosed |
| EP-0211271-A1 | Process for the preparation of veratryl cyanide | BASF Aktiengesellschaft (DE) | 1987-02-25 | — | — | EP | disclosed |
| EP-0142797-A2 | Method for the preparation of acetonitriles substituted in position 2 by an aromatic or heterocyclic substituent | BASF Aktiengesellschaft (DE) | 1985-05-29 | — | — | EP | disclosed |
| EP-0019158-B1 | PROCESS FOR THE PRODUCTION OF M-SUBSTITUTED N-METHYLANILINES | BASF Aktiengesellschaft (DE) | 1982-09-15 | — | — | EP | disclosed |
| EP-0046194-A1 | Process for the preparation of o,o-disubstituted benzoic acids and their salts | BASF Aktiengesellschaft (DE) | 1982-02-24 | — | — | EP | disclosed |
| EP-0019158-A1 | Process for the production of m-substituted N-methylanilines | BASF Aktiengesellschaft (DE) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | CPS1, PHGDH, APEH | TYR 582/4885ESR1 3842/4885ADRA2A 4525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.